Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters.

Gilheeney SW, Kieran MW.

Future Oncol. 2012 May;8(5):549-58. doi: 10.2217/fon.12.51. Review.

PMID:
22646770
[PubMed - indexed for MEDLINE]
2.

Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.

Jones DT, Mulholland SA, Pearson DM, Malley DS, Openshaw SW, Lambert SR, Liu L, Bäcklund LM, Ichimura K, Collins VP.

Acta Neuropathol. 2011 Jun;121(6):753-61. doi: 10.1007/s00401-011-0810-6. Epub 2011 Feb 17.

PMID:
21327941
[PubMed - indexed for MEDLINE]
3.

Characterisation of molecular alterations in microdissected archival gliomas.

Walker C, Joyce KA, Thompson-Hehir J, Davies MP, Gibbs FE, Halliwell N, Lloyd BH, Machell Y, Roebuck MM, Salisbury J, Sibson DR, Du Plessis D, Broome J, Rossi ML.

Acta Neuropathol. 2001 Apr;101(4):321-33.

PMID:
11355303
[PubMed - indexed for MEDLINE]
4.

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas.

Haberler C, Wöhrer A.

Clin Neuropathol. 2014 Mar-Apr;33(2):108-11.

PMID:
24559763
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Anaplastic glioma. Neuropathology, molecular diagnostics and current study concepts].

Wick W, Weller M.

Nervenarzt. 2010 Aug;81(8):928-30, 932-5. doi: 10.1007/s00115-010-2956-1. Review. German.

PMID:
20635074
[PubMed - indexed for MEDLINE]
6.

IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.

Mellai M, Piazzi A, Caldera V, Monzeglio O, Cassoni P, Valente G, Schiffer D.

J Neurooncol. 2011 Nov;105(2):345-57. doi: 10.1007/s11060-011-0596-3. Epub 2011 Jun 4.

PMID:
21643842
[PubMed - indexed for MEDLINE]
7.

Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas.

Miwa T, Hirose Y, Sasaki H, Ezaki T, Yoshida K, Kawase T.

Neurosurgery. 2011 Jan;68(1):206-12. doi: 10.1227/NEU.0b013e3181fd2c2e.

PMID:
21099717
[PubMed - indexed for MEDLINE]
8.

Molecular pathogenesis of pediatric astrocytic tumors.

Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.

Neuro Oncol. 2007 Apr;9(2):113-23. Epub 2007 Feb 27.

PMID:
17327574
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Genetic alterations in pediatric high-grade astrocytomas.

Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS.

Hum Pathol. 1999 Nov;30(11):1284-90.

PMID:
10571506
[PubMed - indexed for MEDLINE]
10.

Distinct genetic alterations in pediatric glioblastomas.

Byeon SJ, Myung JK, Kim SH, Kim SK, Phi JH, Park SH.

Childs Nerv Syst. 2012 Jul;28(7):1025-32. doi: 10.1007/s00381-012-1773-1. Epub 2012 May 9.

PMID:
22570167
[PubMed - indexed for MEDLINE]
11.

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.

Gömöri E, Pál J, Kovács B, Dóczi T.

Diagn Pathol. 2012 Jan 20;7:8. doi: 10.1186/1746-1596-7-8.

PMID:
22264301
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Overview and recent advances in neuropathology. Part 1: Central nervous system tumours.

Robertson T, Koszyca B, Gonzales M.

Pathology. 2011 Feb;43(2):88-92. doi: 10.1097/PAT.0b013e3283426e86. Review.

PMID:
21233669
[PubMed - indexed for MEDLINE]
13.

Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.

Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG.

Neuro Oncol. 1999 Apr;1(2):124-37. Review.

PMID:
11550308
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations.

Mulholland S, Pearson DM, Hamoudi RA, Malley DS, Smith CM, Weaver JM, Jones DT, Kocialkowski S, Bäcklund LM, Collins VP, Ichimura K.

Int J Cancer. 2012 Sep 1;131(5):1104-13. doi: 10.1002/ijc.26499. Epub 2012 Jan 11.

PMID:
22020830
[PubMed - indexed for MEDLINE]
15.

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.

Thon N, Eigenbrod S, Kreth S, Lutz J, Tonn JC, Kretzschmar H, Peraud A, Kreth FW.

Cancer. 2012 Jan 15;118(2):452-60. doi: 10.1002/cncr.26298. Epub 2011 Jun 29.

PMID:
21717448
[PubMed - indexed for MEDLINE]
Free Article
16.

Incorporating molecular tools into clinical trials and treatment for gliomas?

Lassman AB, Holland EC.

Curr Opin Neurol. 2007 Dec;20(6):708-11. Review.

PMID:
17992094
[PubMed - indexed for MEDLINE]
17.

Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.

Mott RT, Turner KC, Bigner DD, McLendon RE.

J Neurosurg. 2008 Feb;108(2):330-5. doi: 10.3171/JNS/2008/108/2/0330.

PMID:
18240930
[PubMed - indexed for MEDLINE]
18.

Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens.

Louis DN, Rubio MP, Correa KM, Gusella JF, von Deimling A.

J Neuropathol Exp Neurol. 1993 Sep;52(5):507-15.

PMID:
8103086
[PubMed - indexed for MEDLINE]
19.

A huge intraventricular congenital anaplastic astrocytoma: case report with histopathological and genetic consideration.

Yamashita S, Ryu S, Miyata S, Uchinokura S, Yokogami K, Uehara H, Moriguchi S, Iwakiri T, Marutsuka K, Ikenoue M, Sawa D, Yamada N, Kodama Y, Takeshima H.

Brain Tumor Pathol. 2012 Apr;29(2):107-12. doi: 10.1007/s10014-011-0071-z. Epub 2011 Dec 3.

PMID:
22139530
[PubMed - indexed for MEDLINE]
20.

Biomarkers classification and therapeutic decision-making for malignant gliomas.

Olar A, Aldape KD.

Curr Treat Options Oncol. 2012 Dec;13(4):417-36. doi: 10.1007/s11864-012-0210-8.

PMID:
22956341
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk